Tag: ABCN.V
-
Aurora (ACB.T) breaks $7 support; ABcann (ABCN.V) acquires Canna Farms & launches sexy rec brand
Today Aurora Cannabis (ACB.T) closed at $6.81 CAD on 20.6 million shares traded. The is the first time Aurora has closed below the $7 support level since December 7th, 2017. It bounced off of that support level in February, April, and May, going on trough-to-peak runs of 59%, 29.3% and 46% respectively, each time it…
-
ABcann (ABCN.V) founder sells 800,000 shares – then resigns
There are legitimate reasons to tell a delinquent off-spring, “I dislike you”. But it’s still something you should never do. We have the same opinion about company insiders off-loading high volumes of a micro-cap stock. It’s crappy behavior. Shareholders (like children) expect stronger leadership. ABcann Global (ABCN.V) is involved in the production of pharmaceutical-grade cannabis…
-
Stop saying ‘this is a good time to buy’.. it’s not. It’s a crash. Back away from the keyboard.
Jesus crap on a pogo stick, you people never learn. So last week, right when we said it would, the weed market began to prolapse. And on social media all I heard was, “This is a great time to buy on dips.” Early this week, it kept rolling downhill, and on social media all I…
-
Called it: Invictus MD Strategies (IMH.V), Abcann (ABCN.V) and DOJA (DOJA.C) defy weed market gravity
Invictus MD Strategies (IMH.V) announced today that it has delivered 120kg of cannabis to Canopy Growth Corp (WEED.T), its first B2B delivery of flower, to be sold through that company’s CraftGrow line alongside PEI’s Island Garden. “On behalf of the Canopy Growth team, I want to congratulate the AB Labs team for achieving this milestone,”…
-
Is ABcann (ABCN.V) good or lucky?
Amidst the rolling waves of dull grey days – have you ever had a brilliant shiny one where it seemed the world was inexplicably fond of you? ABcann (ABCN.V) – a seller of pharmaceutical-grade cannabis – just had a day like that. On January 22, 2018, the intra-day chart looked like this: Normally, when a…
-
ABcann Medical (ABCN.V) talks and walks like a pharmaceutical company
On October 17, 2017 Abcann Medical (ABCN.V) announced the appointment of Paul Lucas as Chair of its Board. Mr. Lucas is the former CEO of GlaxoSmithKline Canada (1994-2012). GlaxoSmithKline (GSK.NYSE) is a venerable UK pharmaceutical company launched in 1848 with laxative pills. After successfully loosening the bowels of Queen Victoria and Oscar Wilde – it…
-
Abcann Medicinals CEO Aaron Keay (PDA.H) reveals company to list next week
In the medical marijuana space, when licensed producers get together to talk about who has the highest quality product, Abcann Medicinals (which will go public in the PDA.H shell) is never outside the conversation. With a thriving wholesale business supplying other LPs now switching to a patient building program and keeping the good stuff for themselves,…
